ClinicalTrials.govpublic full text
PF-03446962 in Relapsed or Refractory Urothelial Cancer
transitional cell carcinoma of bladder, transitional cell carcinoma, metastatic disease, bladder tumors, recurrent, angiogenesis, pf03446962, transforming growth factor beta, activin receptor like kinase 1, monoclonal antibody, locally advanced or metastatic disease, failure of one platinum-based chemotherapy, measurable disease
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 968552
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.